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Abstract 
 
Background: Clean Intermittent self-catheterisation (CIC) is often recommended for people 
with MS.  
Objectives: To determine the variables that affect continuation or discontinuation 
of the use of C I C .  
Methods:  A 3-part mixed method study (prospective longitudinal cohort (n=56), 
longitudinal qualitative interviews (n=20) and retrospective survey (n=456) was 
undertaken which identified the variables that influenced clean intermittent self-
catheterisation continuation/discontinuation. The potential explanatory variables 
investigated in each study were the individual’s age, gender, social 
circumstances, number of urinary tract infections bladder symptoms, presence of co-
morbidity, stage of multiple sclerosis and years since diagnosis, as well as clean 
intermittent catheterization teaching method and intensity. 
Results: For some people with multiple sclerosis the prospect of undertaking clean 
intermittent catheterisation is difficult and may take a period of time to accept before 
beginning the process of using clean intermittent catheterisation. Ongoing support 
from clinicians, support at home and a perceived improvement in symptoms such as 
nocturia were positive predictors of continuation.  In many cases, the development of a 
urinary tract infection during the early stages of clean intermittent catheterisation use 
had a significant detrimental impact on continuation.  
Conclusions: Procedures for reducing the incidence of urinary tract infection during 
the learning period (i.e. when being taught and becoming competent) should be 
considered, as well as the development of a tool to aid identification of a person’s 
readiness to try clean intermittent catheterization. 
 
Background 
Multiple sclerosis is the most common neurological disease of young adults affecting 
more than 100,000 people in the UK in a ratio of 1:3 male to female. Lower urinary tract 
dysfunction is present in 75–80 % of patients with MS and urinary incontinence in more 
than 50 %, and this is influenced by the duration and extent of disease.  Patients most 
commonly report symptoms of urinary urgency, incontinence and frequency, as well as 
the inability to initiate voiding voluntarily.1  
It is thought that clean intermittent catheterisation (CIC) is advocated at some point in at 
least 25% of people with MS2 to assist in overall bladder management especially for 
those with voiding difficulties. In 2008 an expert panel produced a UK consensus 
document on the management of the bladder in people with MS (PwMS).  They 
considered clean intermittent catheterisation (CIC) to be of the greatest importance in 
the management of neurogenic bladder dysfunction caused by MS.3 CIC is more 
effective than indwelling catheterisation for those who can perform it themselves or have a 
carer who can do so for them.4  It reduces the risk of common indwelling catheter-
associated complications such as blockage, and reduces the need for equipment such as 
drainage bags. CIC may also reduce lower urinary tract symptoms (frequency, urgency and 
incontinence) between catheterisation, which can lead to improved self-care and 
independence, with fewer barriers to intimacy and sexual activities.5 However, CIC is not 
always taken up, or if tried is often discontinued in people with MS.6,7 The primary aim 




Data were collected using mixed methods in order to improve the understanding of 
the variables involved in the decision to continue CIC8,9 and comprised three study 
components (Figure 1).  We identified the most probable variables thought to influence 
CIC use through personal communication with experts in the field, including two of the 
authors of a subsequent paper,10 and consultation with a group of MS patients reaching 
consensus on the top 10 (Insert Figure 1).  These 10 potential predictive variables were 
then targeted in our data collection - age, gender, social circumstances, number of 
urinary tract infections (UTIs), bladder symptoms, presence of co-morbid and or MS 
symptoms, stage of MS, years since diagnosis, teaching venue, teaching intensity.  
 
1.1  Prospective Longitudinal Cohort: 
Across 38 UK wide sites we recruited people with MS who had been newly referred to 
the continence service due to bladder symptoms over a 12 month period (May 2013 to 
April 2014). Baseline demographic and symptom characteristics are presented in Table 
1. The target sample size (n=250) for the prospective longitudinal cohort study was based 
on a planned logistic regression analysis using the 10 independent variables mentioned 
above and shown in Table 2, and assuming that the proportion discontinuing with CIC 
was 40% following the sample size guidelines of Peduzzi et al 1996.11 
All participants completed disease-specific (ICIQ-LUTS, FLUTS) and general health 
status (EQ-5D)12 questionnaires at 4, 8 and 12 months after referral (Table 3).  The 
ICIQ-FLUTS has 13 questions around severity of bladder symptoms with responses 
scoring from 0 least and 4 worse scenario13; and ICIQ-LUTSqol with 22 questions on 
impact on daily activities with 1 indicating least and 4 greatest impact.14   These 
questionnaires have Grade A validity, reliability and responsiveness which have been 
established in several non-neurogenic data sets.15,16 These were used as, at the time of 
study inception, they seemed the most appropriate questionnaires to assess severity of 
bladder symptoms and impact on daily activities. We had used these questionnaires in other 
populations and they have been also been used in the MS population.17,18 The EQ-5D12 is 
one of the most commonly used generic questionnaires to measure health-related  quality 
of life self-assessment in 5 dimensions as well as the EQ-VAS which records the subject’s 
perceptions of their own current overall health and can be used to monitor changes with 
time.  
The number of UTIs were as reported by the participant at telephone follow-up call and 
included all symptomatic UTIs for which antibiotics had been taken, but not 
necessarily laboratory-confirmed UTI (Table 4).   
 
Analysis 
Quantitative data analysis included summary statistics (proportions for categorical 
variables, means and SDs for continuous variables) describing, for all participants, the 
demographic characteristics and quality of life measures over the study time-points using 
responses provided by participants.  
Participants were grouped into four categories based on their CIC use: CIC not 
recommended; CIC recommended but not started – resistors; CIC started but stopped – 
discontinuers; and CIC started and continuing at the one year follow-up - continuers. This 
paper focusses on the latter two groups only.  Discontinuers and continuers were compared 
using Pearson chi-square tests for categorical variables and two-sample t−tests for 
continuous variables.  Independent samples Mann-Whitney U-tests for were used for 
continuous data if the overall sample was not normally distributed (Shapiro-Wilk statistics 
were used to test normality).  For outcomes collected at multiple time points (ie ICIQ FLUTS 
and LUTS), discontinuers and continuers were compared using repeated measures mixed 
models with restricted maximum likelihood, adjusting for age, sex, duration of symptoms, 
type of MS and general health status, with participant fitted as a random effect. Data 
collected at baseline and 12 months (i.e. EQ-5D) were compared at 12 months using analysis 
of covariance adjusting for the same variables used in the repeated measures models along 
with the baseline measure.  Binary logistic regression was used to identify if any of the fixed 
effects used in the repeated measures model are potential predictors of CIC continuation at 
12 months.  Linearity assumptions and normality of error distributions were examined by 
inspection of residual plots for the linear models, and the goodness of fit for the logistic 
model was examined with a Hosmer-Lemeshow test.  The significance level used was 5%, 
and exact significance (rather than asymptotic significance) was reported to correct for 
small numbers of responses where applicable.  Statistical analyses were performed using 
SPSS v21 (IBM, Armonk, NY).  
.  
1.2 Qualitative Interviews 
In-depth one-to-one interviews were undertaken with a purposive sample (variance 
based on age, gender, type of MS and disability level) of patients from the longitudinal 
cohort who had commenced CIC following referral to the continence service. We aimed 
for a sample of 20 people, which we anticipated would provide saturation of the 
concepts.19 Telephone interviews were conducted with each individual at two specific 
time-points (4 and 12 months after recruitment) by DM (a specialist physiotherapist 
and academic researcher). Interviews lasted between 30 and 45 minutes and were 
audio recorded. The focus of the interviews was to allow participants to discuss the 
variables they felt were important to continuation and discontinuation of CIC. 
All interviews were transcribed verbatim and data were analysed using Framework 
Analysis.20  A subset of data were selected and three of the team (DM, AT, CB) 
familiarised themselves with the data.  From that, an initial thematic framework was 
developed and applied across the data.  The thematic framework was revisited and 
expanded as necessary when applied to the broader data set. Charts were developed 
around the key themes and compared to generate an understanding of the variables 
that affect continuation and discontinuation. 
 
1.3 On-line Survey 
An on-line survey was disseminated through the UK-based MS Registry portal 
(https://www.ukmsregister.org/). All members of the Registry (which is voluntary) are 
alerted by email to the availability of such research, and can access the portal to respond. 
An initial explanatory paragraph introduced the aims and methods of the study. The 
content and phrasing of the questions of this survey were informed by the qualitative 
interviews and the 10 potential predictor variables outlined earlier. (Appendix 3). Once 
accessed the survey gave a brief background to the study, ethical approval details and 
contact details of the researcher who could answer questions.  Comparison of those 
who had continued using CIC and those who had discontinued was undertaken as per 
the analysis of the longitudinal study data. 
 
Data Triangulation 
To develop the analysis and drive the action and impact of our research we have 
combined the methods using a triangulation protocol.21 Triangulation is a powerful 
technique that facilitates validation of data through cross verification from two or more 
sources. In particular, it refers to the application and combination of several research 
methods in the study of the same phenomenon.  In this study we used the 10 regression 
variables and if they were identified in the longitudinal, qualitative and survey studies. If all 
three studies identified a particular variable as having an impact on ISC then this was Total 
Agreement, if only 2 this was Partial agreement.  
 
1.4 Ethical approval 
Ethical approval was granted by the West of Scotland REC 2 committee 11/AL/0117 on 
24th March 2011.   
 
RESULTS 
Prospective Longitudinal Cohort 
From the 260 patients who were interested in taking part in the trial 224 participants 
completed the Consent form and 204 returned the base-line from 38 sites across the UK 
(Figure 2). This number fell short of the target sample size of 250. From the 204, 56 
(27%) commenced CIC (Continued and discontinued Groups) of these 13 (23%) 
(Discontinued Group) stopped using CIC within the one-year follow-up, 6 within the first 
4 months and the remaining 7 by month 8. A further 13 (6%) were recommended to 
commence CIC but chose not to do so. Ninety per cent of participants who did not 
commence CIC (n=119/148) completed the Outcome questionnaires at 12 months, 100% 
of those that had commenced CIC (56/56) completed the questionnaires at 12 months.  
(Insert Figure 2) 
Baseline demographic and symptom data are shown in Table 1. Comparative analysis has 
been used to compare (in this paper) those that commenced CIC and continued to 
those that commenced and discontinued. 
There was no significant difference in the age, gender, severity of bladder symptoms 
or length of time since diagnosis at baseline between those that subsequently 
discontinued and those that continued CIC. As shown in Table 1 there was however a 
significant difference in the severity of symptoms related to MS (χ2=10.923, df=4, 
p=0.0459) with a greater proportion of discontinuers reporting problems of balance and 
fatigue (Table 1).  
Although not significantly different the majority of those that continued had been 
taught in clinic and had been seen 4-6 times compared to once or twice.  Those that 
discontinued CIC were more likely to either live alone or be single parents compared to 
those that continued  (Table 2). There were no significant differences in the Total 
LUTS and FLUTS scores between those that discontinued and those that continued at 
any time-point (Table 3). 
More participants who continued with CIC had reported UTIs at baseline (51%) compared 
with those who discontinued (23%) (Chi square test p=0.064).  There were significantly 
more UTIs at 8 months in those that discontinued CIC compared to those that continued 
(Chi Square test, p=0.019). (Table 4) 
The logistic regression model showed no evidence of any independent risk variables 
significantly associated with discontinuation. (see model output in Appendix 2) 
 
Qualitative Longitudinal Interviews  (See Appendix 1 for characteristics of participants) 
Twenty participants took part in the interviews all of whom started CIC; all 20 were 
interviewed at four months and 19 again at 12 months (39 interviews). There were 16 
female and four male participants with a mean age of 53 years. Nine participants reported 
having Relapsing Remitting, four Primary Progressive and seven Secondary Progressive MS. 
Four participants did not use any aids when walking, seven used two sticks or rollator and 
nine primarily used wheelchairs/scooters. All interview participants self-catheterised (i.e. 
no carer involvement).  At the one- year follow-up six participants had discontinued CIC. 
Brief findings from the analysis is reported below. Supportive qualitative information is 
available as supplementary data.  
 
Demographic variables (age, gender and social circumstances) 
There was no obvious difference in the demographic data between those that 
continued or discontinued 
 
Teaching method, place, intensity and support 
Generally, starting CIC was suggested by the continence nurse with feelings often 
changing from being against trying to being ready to try.   
  
Bladder symptoms, including UTIs 
The two main benefits of CIC raised by participants were sleeping better at night, as 
a result of reduced nocturia, and being more confident and comfortable when going out/ 
going shopping. 
 
About MS (symptoms, type of MS, and time since diagnosis) 
Participants did not raise MS type or time since diagnosis when asked about variables that 
support continuation or discontinuation. There was a contrast between those who felt that 
by starting CIC it was giving in to the disease and losing control’ whilst those that went on to 
continue using CIC stated that they ‘felt more in control’ being able to go out without 
worrying about accessing the toilets. 
 
On-line Survey (See Appendix 3 for Online Survey) 
Of the 11,000 registrants 2227 (20%) responded to the survey; from the responders 
454(20%) had used CIC, of whom 167 (36%) had then discontinued, and 291 (64%) were 
continuing to use CIC. The mean age of all responders was 47.5 (SD 11.4) years, with 1578 
(71%) females and 645(28%) male. (Table 5). There was no significant difference in the 
gender ratio or age of those who had stopped compared to those who continued to use 
CIC (Table 5). The average length of time that CIC was used by those that had stopped 
was 22 (SD 33) months, although 41/167 (25%) had stopped within one month. The 
primary reasons for stopping CIC were: an increase in number of UTIs (51/167, 31%); 
poor dexterity and or pain (35/167, 21%); felt it was humiliating/degrading (20/167, 
12%); no longer necessary due to improvement (16/167, 10%); using CIC did not improve 
symptoms (16/167, 10%). 
Negativity was the overwhelming feeling in both groups when CIC was first suggested 
with some expressing that it was the fear of ‘loss of control’ that was the worst thought. 
Improvements in symptoms of emptying, leakage, nocturia and frequency were the 
most often reported changes in symptoms in those that continued to use CIC.  In those 
that had discontinued more said their emptying, number of UTIs and QoL were worse. 
(Table 6).  
 
Data Triangulation (Figure 3) 
There was total agreement that age or gender or length of time since MS diagnosis did not 
impact on continuation of CIC but MS symptoms such as poor dexterity and frequency of 
UTIs did affect continuation. There was also total agreement that professional support and 
support at home were important for continuation. There was partial agreement that if  
there was significant improvements in symptoms (the qualitative and survey data) patients 
were more likely to continue with CIC. Two studies (partial agreement) agreed that the type 
of MS did not seem to impact on continuation; however the type of MS was not brought up 
in the interviews.  
 
Discussion 
Our research question i.e. ‘what determines the continuity of ISC’ was recognised to be 
complex from the outset and therefore a mixed methods was used with integration of 
findings using Data Triangulations 21,22. (Figure 3 Data Triangulation). Several important 
conclusions may be drawn from the information gathered about the ten variables we 
explored in detail in this study.  Age, gender, type of MS and time since diagnosis had no 
effect on continuation with CIC. Being taught at home was commonly preferred and 
there is a tentative suggestion that it may lead to a greater likelihood of continuing. 
Ongoing clinician support and family support at home both improved chances of 
continuing as did the reduction in nocturia experienced. UTI’s during the initial period of 
use and poor balance, dexterity and fatigue were identified as leading to to greater 
discontinuation. 
One key variable relates to the development, and perception of the development of 
UTIs.  Most patients who stop CIC do so within the first 1-3 months and the occurrence 
of one or more UTIs during this period significantly impacts on continuation (See Figure 
3). 
This is an important finding as CIC has been shown to be efficacious in some 
populations e.g. spinal cord injuries where the main criteria for success is continence, 
ability to self-catheterise and the preservation of kidney function.23 A reduction or an 
increase in the incidence of UTI can be difficult to determine due to poor definition of 
UTI, mixed study populations and different types of catheters. However, it would seem 
within the MS population any perceived increase is a predictive factor for 
discontinuation and there is evidence that during the learning period an infection may be 
more likely to develop.  A more focussed strategy at this time may help with 
continuation and therefore the longer-term benefits may become more apparent to the 
patiet; for example, using a low-fidelity simulation may help to increase self-
confidence25 and it may be worth exploring the potential benefits of using prophylactic 
antibiotics during the learning phase, however this needs to be further explored in 
relation to a possible increase resistance of urinary bacteria.26  
Variables relating to the nature of MS as an illness (for example, poor balance and 
dexterity) and variables relating to the clinical and personal support available seemed to 
influence a person’s readiness to undertake CIC. There appeared to be no correlation 
between the initial reaction to the suggestion of using CIC (accepting versus opposing) 
and continuation/discontinuation. However, the data also identified that the individual 
had to be “ready” – emotionally and physically – to be able to add another ‘burden’ to 
their daily life. For some there was a definite change of perception over time and for 
those in which benefit outweighed burden continuation was more usual but where this 
was not evident then discontinuation was more usual. It was evident that for many 
making the decision to start CIC was a major step and support for the individual with 
MS, both from the person teaching CIC and from their family members was important to 
encourage them to overcome both the practical issues and feelings of negativity. A 
recently published review on the quality of life of ISC users and their caregivers24 
concluded that the QoL of patient’s who use ISC can be determined by improvement of 
urinary symptoms and self-confidence with emphasis on the importance of adequate 
professional support.  
The current study has strengths and limitations. It is the first study that brings 
together prospective longitudinal quantitative and qualitative, and retrospective data 
relating to variables affecting continuation and discontinuation of CIC use in an MS 
population. However, recruitment was slower than expected and the reduced numbers 
of CIC users recruited in the longitudinal study (n=56) meant that the logistic regression 
analysis was not statistically powered to allow us to draw strong conclusions about 
independent risk variables significantly associated with discontinuation. We had 
anticipated (from talking with clinicians) that a recommendation to undertake CIC 
following referral to the continence service would occur in around 50%, whilst in fact it 
was only 34% (69/204).  Even more surprising was the number of participants in the 
longitudinal cohort who did not agree during the one-year follow-up to attempt CIC, 
although recommended to do so - 13/69 (19%). This is an important group to follow-up 
in order to understand the transition from complete rejection of the idea of CIC to 
agreeing to try it, and is the focus of further research. 
 
Conclusion 
Although CIC may benefit many people with MS, continuation is dependent on the 
individual’s perception of improvement in symptoms versus the burden of use. Using 
CIC can often be seen as ‘giving in to the disease’ and many require time to ‘get their 
heads’ around the idea. Symptom improvement, clinical and family support are 
important variables when the patient is learning the technique, however the most 
important factor that precipitates discontinuation is if the person links catheter use 
with the development of a UTI. The development of a UTI can have major health 
implications: it can negatively affect the person’s MS, can take a long time to recover 
from fully, and can lead to feelings of guilt if the individual assumes they have caused the 
infection. Further research is required to determine if prophylactic use of antibiotics 
would prevent the development of UTIs during the learning stages of CIC keeping in 
mind the co-founding possibility of increasing urinary bacteria resistance. In addition, 
clinicians need to be able to identify when patients are ready and are available to offer 
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